Lingling Wu

机构：University of Science and Technology of China, Guangxi University, Peking University, State Administration of Traditional Chinese Medicine of the People's Republic of China, Chinese PLA General Hospital, Ministry of Education, Guangxi University of Chinese Medicine, Peking University Third Hospital, Ruikang Affiliated Hospital of Guangxi Medical University, Henan Provincial Center for Disease Control and Prevention · ORCID：0000-0002-7166-3966

发表论文 101 篇 · 总被引 1812 次 · h-index 26

代表论文

• Depleting profibrotic macrophages using bioactivated in vivo assembly peptides ameliorates kidney fibrosis (2024 · Cellular and Molecular Immunology · 被引 39)
• Cell-intrinsic PD-L1 ablation sustains effector CD8+ T cell responses and promotes antitumor T cell therapy (2024 · Cell Reports · 被引 19)
• Identification of glutamine as a potential therapeutic target in dry eye disease (2025 · Signal Transduction and Targeted Therapy · 被引 18)
• Targeting the NLRP3 in macrophages contributes to senescence cell clearance in radiation-induced skin injury (2025 · Journal of Translational Medicine · 被引 8)
• Nocardia rubra cell-wall skeleton mitigates whole abdominal irradiation-induced intestinal injury via regulating macrophage function (2024 · Burns & Trauma · 被引 8)
• ATP11B Modulates Microglial Lipid Metabolism and Alleviates Alzheimer's Disease Pathology (2025 · MedComm · 被引 7)